Table 1.
Between Persons/Person-Level | M (SD) | % | |
---|---|---|---|
Age [range: 19–71] | 38.99 (10.85) | -- | |
Race/ethnicity | |||
White | -- | 63% | |
Black | -- | 19% | |
Latinx | -- | 18% | |
Education | |||
High school or less | -- | 11% | |
Some college | -- | 31% | |
Associate’s/technical degree or some college | -- | 11% | |
College or graduate degree | -- | 48% | |
Employed full-time | -- | 53% | |
Income [range: 1–8] | 3.33 (1.80) | -- | |
City size [range: 1–6] | 4.94 (1.46) | -- | |
Years living with HIV [range: 0–32] | 8.62 (8.00) | -- | |
HIV knowledge [range: 0–1] | 0.91 (0.14) | -- | |
Undetectable viral load | -- | 81% | |
HIV stigma (3 months) [range: 1–4] | 2.62 (0.69) | -- | |
Within Persons/Time-Varying | M (SD) | % | ICC |
Asked a partner about PrEP (outcome)a | -- | 62% | .64 |
Frequency of heavy alcohol use before/during sexa [range: 0–6] | 0.61 (1.37) | -- | .53 |
Stimulant use before/during sexa | -- | 33% | .84 |
Other drug use before/during sexa | -- | 65% | .76 |
Number of male sexual partnersa [range: 1–29] | 6.29 (6.36) | -- | .68 |
Engagement in group sexa | -- | 37% | .66 |
Personal responsibility [range: 1–5] | 3.56 (0.93) | -- | .72 |
Antiretroviral therapy (ART) adherence | -- | 78% | .63 |
Disclosure to all recent partnersa | -- | 54% | .67 |
Disclosure self-efficacy [range: 0–4] | 2.60 (1.13) | -- | .77 |
Notes. Between-persons factors were assessed at baseline unless otherwise indicated.
During the past 3 months.